We are live on ! Find out more
IIA

IPG Investment Advisors Portfolio holdings

AUM $582M
1-Year Est. Return 33.22%
This Fund
S&P 500
This Quarter Est. Return
+4.03%
1 Year Est. Return
+33.22%
3 Year Est. Return
+78.57%
5 Year Est. Return
+87.09%
10 Year Est. Return
+385.27%
AUM
$359M
AUM Growth
+$2M
Cap. Flow
-$7.42M
Cap. Flow %
-2.07%
Top 10 Hldgs %
49.85%
Holding
163
New
19
Increased
44
Reduced
53
Closed
23

Top Buys

Rank Stock Value
1
WBD icon
Warner Bros
WBD
+$10.7M
2
STX icon
Seagate
STX
+$8.83M
3
U icon
Unity
U
+$8.53M
4
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$7.2M
5
NTR icon
Nutrien
NTR
+$6.81M

Top Sells

Rank Stock Value
1
OI icon
O-I Glass
OI
+$14.1M
2
WDC icon
Western Digital
WDC
+$13.2M
3
ANF icon
Abercrombie & Fitch
ANF
+$8.14M
4
MGA icon
Magna International
MGA
+$7.7M
5
GT icon
Goodyear
GT
+$6.65M

Sector Composition

Rank Sector Weight
1 Technology 23.02%
2 Industrials 13.27%
3 Communication Services 11.02%
4 Consumer Discretionary 10.66%
5 Materials 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCPH
126
DELISTED
scPharmaceuticals
SCPH
$103K 0.03%
14,300
BBVA icon
127
Banco Bilbao Vizcaya Argentaria
BBVA
$156B
$92K 0.03%
15,305
-47,000
-75% -$254K
IFRX icon
128
InflaRx
IFRX
$271M
$80.3K 0.02%
25,900
CELU icon
129
Celularity
CELU
$20.3M
$60.3K 0.02%
4,677
ASTS icon
130
AST SpaceMobile
ASTS
$21.5B
$59K 0.02%
+12,250
New +$73.9K
OTLY
131
Oatly Group
OTLY
$438M
$29.6K 0.01%
+850
New +$32.4K
PLBY icon
132
Playboy Inc
PLBY
$141M
$28.7K 0.01%
10,430
ONCT
133
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$23.7K 0.01%
1,185
CTMX icon
134
CytomX Therapeutics
CTMX
$754M
$20K 0.01%
12,500
OPK icon
135
Opko Health
OPK
$1.02B
$18.8K 0.01%
15,000
+5,000
+50% +$7.88K
ML
136
DELISTED
MoneyLion Inc.
ML
$9.92K ﹤0.01%
533
TMQ
137
Trilogy Metals
TMQ
$656M
$8K ﹤0.01%
14,850
ZKIN icon
138
ZK International Group
ZKIN
$61.9M
$6.63K ﹤0.01%
2,325
ORTX
139
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$5.23K ﹤0.01%
1,410
PHAS
140
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$864 ﹤0.01%
28,700
ADVM
141
DELISTED
Adverum Biotechnologies
ADVM
-1,000
Closed -$9.5K
ANF icon
142
Abercrombie & Fitch
ANF
$5B
-523,740
Closed -$8.14M
ATER icon
143
Aterian
ATER
$5.37M
-1,258
Closed -$18.7K
AXP icon
144
American Express
AXP
$230B
-5,587
Closed -$754K
AZN icon
145
AstraZeneca
AZN
$250B
-1,993
Closed -$219K
CCL icon
146
Carnival Corporation Ltd
CCL
$39.7B
-18,551
Closed -$130K
FLOT icon
147
iShares Floating Rate Bond ETF
FLOT
$10.5B
-45,108
Closed -$2.27M
KALA icon
148
KALA BIO
KALA
$14.5M
-6
Closed -$3.17K
KSS icon
149
Kohl's
KSS
$2.19B
-249,088
Closed -$6.26M
LULU icon
150
lululemon athletica
LULU
$14.6B
-722
Closed -$202K

Similar funds

IPG Investment Advisors's Q4 2022 Portfolio in Review

As of Q4 2022, IPG Investment Advisors held 163 positions worth $359M, up 0.56% from $357M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

IPG Investment Advisors's Q4 2022 filing shows 19 new, 44 increased, 53 reduced and 23 closed positions. Its largest new stake was Seagate: 166,080 shares worth $8.74M. The largest sale was O-I Glass, an estimated $14.1M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Industrials and Communication Services.

  • IPG Investment Advisors's largest Q4 2022 buy was Seagate: 166,080 shares worth $8.74M.
  • IPG Investment Advisors added most to Warner Bros in Q4 2022, an estimated $10.7M increase.
  • IPG Investment Advisors's biggest Q4 2022 reduction was Magna International, cutting an estimated $7.7M.
  • IPG Investment Advisors fully exited O-I Glass in Q4 2022, selling an estimated $14.1M.
  • IPG Investment Advisors's ten largest holdings make up 50% of its $359M portfolio in Q4 2022.
  • IPG Investment Advisors opened 19 new positions and closed 23 in Q4 2022.
  • IPG Investment Advisors's portfolio value rose 0.56% quarter-over-quarter to $359M.

Based on IPG Investment Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.